Pharma Journalist -

Ocugen, Inc., and Bharat Biotech announced they have entered into a definitive agreement to co-develop, supply, and commercialize Bharat Biotech’s COVAXIN, an advanced stage…
Read More...

Engrail Therapeutics announced that it has acquired NeuroCycle Therapeutics, a company focused on sub-type selective GABA-A modulation. The acquisition strengthens Engrail’s presence in…
Read More...

Ampio Pharmaceuticals, Inc. a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced early positive data…
Read More...

Aeterna Zentaris Inc. through its wholly-owned subsidiary Aeterna Zentaris GmbH a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests…
Read More...

SMi Reports: Three AI in drug discovery start-ups to join the conference GlamourousAI, Cloud Pharmaceuticals and Envisagenics , who will be speaking at the 2nd Annual AI in Drug…
Read More...

Ribon Therapeutics, a clinical stage oncology company developing therapeutics targeting stress support pathways, announced it has entered into an exclusive license agreement with Ono…
Read More...

Gilead Sciences, Inc. and Gritstone Oncology, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration with a…
Read More...

ZebiAI, Inc., a biotech company focused on improving human health by powering machine learning (ML) to source novel targets and discover new therapeutics, announced a strategic…
Read More...

Eli Lilly and Company has partnered with local health systems to launch dedicated infusion center locations serving central, northern, and now southern Indiana that are intended to…
Read More...